These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chromosome study in patients with psoriasis treated with methotrexate]. De Luca M; Rossi A; Ventruto V G Ital Dermatol Minerva Dermatol; 1970 Mar; 45(3):153-6. PubMed ID: 5467667 [No Abstract] [Full Text] [Related]
3. Degranol-induced chromosome aberrations in a culture of leukocytes of persons of different sexes and ages. Kuleshov NP Sov Genet; 1974 May; 8(3):378-84. PubMed ID: 4846204 [No Abstract] [Full Text] [Related]
6. [Prospects for psoriatic patients treated with methotrexate (author's transl)]. Jandová E Cesk Dermatol; 1981 Feb; 56(1):30-3. PubMed ID: 7214556 [No Abstract] [Full Text] [Related]
7. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis. Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967 [TBL] [Abstract][Full Text] [Related]
8. Chromosome aberrations in affected and unaffected skin of patients with psoriasis. Petersen GB; Christiansen JV; Voetmann E; Therkelsen AJ Acta Derm Venereol; 1974; 54(2):147-51. PubMed ID: 4133021 [No Abstract] [Full Text] [Related]
9. [Psoriasis and methotrexate. Treatment of 50 cases]. Carrillo Casaux D; Carrillo Montesinos JM Actas Dermosifiliogr; 1974; 65(5-6):265-70. PubMed ID: 4467699 [No Abstract] [Full Text] [Related]
10. Methotrexate in psoriatic arthritis: a retrospective study. Kragballe K; Zachariae E; Zachariae H Acta Derm Venereol; 1983; 63(2):165-7. PubMed ID: 6189337 [TBL] [Abstract][Full Text] [Related]
11. Etanercept combined with methotrexate for high-need psoriasis. Driessen RJ; van de Kerkhof PC; de Jong EM Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. Gisondi P; Cotena C; Tessari G; Girolomoni G J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022 [TBL] [Abstract][Full Text] [Related]
15. The treatment of psoriasis vulgaris: 1% topical methotrexate gel. Eskicirak B; Zemheri E; Cerkezoglu A Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386 [TBL] [Abstract][Full Text] [Related]
16. The use of methotrexate in the treatment of psoriasis. Superfon NP J Am Osteopath Assoc; 1968 Jan; 67(5):531-6. PubMed ID: 5183590 [No Abstract] [Full Text] [Related]
17. In vitro and in vivo cytogenetic effects of 3-(bis(2-chloroethyl)amino)-4-methylbenzoic acid (NSC-146171; IOB 82) in human peripheral leukocytes. Popescu NC; Costachel O; Liciu F; Cioloca L Cancer Chemother Rep; 1973 Feb; 57(1):29-32. PubMed ID: 4704099 [No Abstract] [Full Text] [Related]
18. [Chromosome study in 14 psoriatic patients treated with hydroxyurea and azathioprine]. Rossi A; Sebastio L; Ventruto V Minerva Med; 1973 May; 64(32):1728-32. PubMed ID: 4713752 [No Abstract] [Full Text] [Related]
19. [On the effectiveness of methotrexate in the treatment of psoriasis vulgaris]. Jubin E Dermatologica; 1966; 132(2):76-88. PubMed ID: 5955351 [No Abstract] [Full Text] [Related]
20. Is methotrexate safe in the treatment of psoriatic patients? Al-Waiz MM; Jafar SJ Saudi Med J; 2004 Apr; 25(4):536-7. PubMed ID: 15083237 [No Abstract] [Full Text] [Related] [Next] [New Search]